Workflow
ZACKS
icon
Search documents
Dutch Bros Order-Ahead Gains Momentum: Is Throughput the Next Lever?
ZACKS· 2025-09-22 17:16
Key Takeaways Order-ahead hit 11.5% of transactions in Q2, with strong uptake in new markets.Throughput gains from dashboards and labor models lifted same-shop sales 6.1% in Q2.Dutch Bros added 31 shops in Q2, topping 1,040 units, with 2025 openings on track to exceed 160.Dutch Bros Inc. (BROS) is sharpening its focus on digital convenience and operational execution, with order-ahead and throughput initiatives becoming increasingly important traffic drivers.In the second quarter of 2025, order-ahead account ...
MDB Shares Jump 39% YTD: Should You Add the Stock to Your Portfolio?
ZACKS· 2025-09-22 17:16
Key Takeaways Atlas adoption is expected to rise in fiscal Q3 as AI use cases move from pilots to full-scale deployment.MongoDB's AI position expanded via the Voyage AI deal, enhancing embeddings and search relevance.MDB expects fiscal 2026 revenues between $2.34B and $2.36B, reflecting 17.5% annual growth.MongoDB (MDB) shares have advanced 38.9% year to date, outperforming the Zacks Computer and Technology sector’s appreciation of 22.3% and the Zacks Internet Software industry’s growth of 26.5%. The develo ...
Visa vs. Mastercard: Which Payments Giant is the Smarter Buy Today?
ZACKS· 2025-09-22 17:16
Core Insights - The payments industry is primarily dominated by Visa Inc. and Mastercard Incorporated, which are integral to the global digital transaction ecosystem as cash usage declines [1][2] - Investors are evaluating which company presents a better investment opportunity amid evolving consumer spending habits and macroeconomic uncertainties [2][3] Visa Overview - Visa is the largest player in global payments, operating in over 200 countries, and has shown steady transaction volume growth even during economic downturns [4] - In fiscal 2023, Visa's processed transactions increased by 10.4%, with projections of 10% growth in 2024 and an average of 10.2% in the first nine months of 2025 [4] - Visa's net revenues for the latest quarter reached $10.2 billion, a 14.3% year-over-year increase, driven by strong payments volume and cross-border transactions [5] - Visa's cross-border volume grew by 12% year-over-year, while its adjusted operating margin was 67.5%, surpassing Mastercard's 59.9% [5][6] - Visa's dividend yield is 0.7%, higher than Mastercard's 0.5%, and its long-term debt-to-capital ratio is 33.6%, significantly lower than Mastercard's 70.7% [6] Mastercard Overview - Mastercard is recognized for its higher growth potential, focusing on credit transactions and international business, which benefits from trends like the rebound in international travel [9] - In the last quarter, Mastercard's net revenue was $8.1 billion, reflecting a 16.8% year-over-year growth, outperforming Visa [12] - Mastercard's gross dollar volume increased by 9.4% to $2.6 trillion, compared to Visa's 7.5% rise to $4.3 trillion [12] - Mastercard's free cash flow was $13.6 billion in 2024, and its return on invested capital stands at 40.3%, significantly higher than Visa's 27.2% [13][14] - Zacks estimates indicate Mastercard has stronger earnings momentum, with revenue growth forecasts of 15.1% compared to Visa's 10.9% [15] Valuation and Performance Comparison - Visa trades at a forward earnings multiple of 26.43X, while Mastercard trades at 32.13X, reflecting investor confidence in Mastercard's growth outlook [18] - Year-to-date, Mastercard shares have increased by 10.2%, outperforming Visa's 7.4% rise and the industry's 2.3% growth [21] Conclusion - Both Visa and Mastercard are strong players in the payments sector, with Visa offering stability and consistent returns, while Mastercard presents a sharper growth trajectory and superior capital efficiency [24][25] - With the ongoing growth in international travel and digital payments, Mastercard is positioned to capture significant growth opportunities, making it a more compelling investment at this time [25]
JD Strengthens Supply Chain Globally: Can Logistics Unlock More Upside?
ZACKS· 2025-09-22 17:16
Core Insights - JD.com's logistics arm, JD Logistics (JDL), is experiencing rapid growth, with Q2 2025 revenues reaching RMB 51.6 billion, a 16.6% year-over-year increase, driven by strong performance in both internal and external businesses [1][10] Group 1: Expansion and Strategy - The launch of JoyExpress in Saudi Arabia marks JDL's first self-operated express delivery service overseas, indicating a strategic push for international expansion, with plans to double overseas warehouse capacity by the end of 2025 [2][10] - JDL operates over 130 warehouses across 23 countries, managing over 1.3 million square meters of space, which enhances its global supply chain network [3][10] Group 2: Technological Advancements - JDL is focused on increasing capacity and efficiency through last-mile delivery enhancements and investments in automation and AI technologies, including the deployment of the "Zhilang" smart warehousing system in major Chinese cities [4] Group 3: Market Position and Competition - JDL's tech-driven model and expanding global reach position it favorably in a supply chain market projected to grow at an 11.2% compound annual rate through 2030, suggesting logistics strength will be a key driver for JD's long-term growth [5] - Alibaba's Cainiao and Amazon are significant competitors, with Alibaba leveraging a platform model and Amazon utilizing advanced robotics and a hybrid retail model to enhance efficiency and customer experience [6][7] Group 4: Financial Performance and Valuation - JD.com shares have declined 2.9% year-to-date, contrasting with a 14.9% return in the Zacks Internet - Commerce industry [8] - JD.com is trading at a forward price-to-earnings ratio of 11.35X, significantly lower than the industry's 25.34X, indicating a favorable valuation [11] - The Zacks Consensus Estimate for JD's full-year 2025 revenues is $183.33 billion, reflecting a 14.04% year-over-year growth, while earnings are projected at $2.68 per share, a 37.09% decline from 2024 [14]
ODFL Stock Down 26.2% Y/Y: Will the Plunge Continue Throughout 2025?
ZACKS· 2025-09-22 17:10
Key Takeaways ODFL's Q3 earnings estimate was cut 10.2% to $1.23, signaling weaker near-term performance. Shares dropped 26.2% in a year versus a 22.7% fall in the Transportation - Truck industry. LTL tons per day fell 9.3%, pressuring revenue growth despite pricing discipline.Old Dominion Freight Line’s (ODFL) shares have had an unimpressive run in a year. Shares of this trucking company have plunged 26.2% in the same period, underperforming its industry’s 22.7% fall.Image Source: Zacks Investment Researc ...
SNY & REGN's Dupixent Receives CHMP Backing for Urticaria in EU
ZACKS· 2025-09-22 17:06
Core Insights - Sanofi and Regeneron received a positive opinion from the European Medicines Agency's Committee for Medicinal Products for Human Use recommending the approval of Dupixent for chronic spontaneous urticaria in adults and adolescents [1][2] Group 1: Product Approval and Market Potential - The recommendation targets patients aged 12 years and older with moderate-to-severe chronic spontaneous urticaria who have not responded adequately to antihistamines and are naive to anti-immunoglobulin E therapy [2] - Dupixent was previously approved by the FDA for this indication in April 2025, marking it as the first new targeted therapy for chronic spontaneous urticaria in over a decade [3][4] - Dupixent is already approved for multiple conditions, including severe chronic rhinosinusitis, severe asthma, and atopic dermatitis, with its approval for chronic spontaneous urticaria being its seventh indication in the U.S. [4][11] Group 2: Clinical Data and Efficacy - The positive opinion for Dupixent's approval in the EU is based on Phase III studies that demonstrated significant reductions in itch and hives compared to placebo [9][10] - Both primary and secondary endpoints were met in the studies, showing improved disease control with Dupixent [10] - Safety data from the studies were consistent with the known safety profile of Dupixent in its other approved indications [11] Group 3: Financial Performance - In the first half of 2025, Dupixent generated global product sales of €7.3 billion, reflecting a growth of 20.7% at constant exchange rates [7][13] - Sanofi projects that Dupixent could achieve approximately €22 billion in sales by 2030 [7][13] Group 4: Market Context - Year to date, Sanofi's shares have decreased by 2.5%, while the industry has seen a growth of 0.9% [5]
Gold Mining ETF (SGDM) Hits New 52-Week High
ZACKS· 2025-09-22 17:06
Group 1 - The Sprott Gold Miners ETF (SGDM) has reached a 52-week high and is up 121.09% from its 52-week low price of $26.60 per share [1] - The underlying index, Solactive Gold Miners Custom Factors Index, tracks larger-sized gold companies listed on Canadian and major U.S. exchanges, with an annual fee of 50 basis points [1] - The recent performance of gold is influenced by geopolitical tensions and increased demand for safe-haven assets, alongside the Federal Reserve's rate cuts [2] Group 2 - SGDM is expected to maintain strong performance in the near term, indicated by a positive weighted alpha of 104.17, suggesting potential for further gains [3]
All You Need to Know About Citizens Financial Group (CFG) Rating Upgrade to Buy
ZACKS· 2025-09-22 17:01
Citizens Financial Group (CFG) could be a solid addition to your portfolio given its recent upgrade to a Zacks Rank #2 (Buy). This upgrade is essentially a reflection of an upward trend in earnings estimates -- one of the most powerful forces impacting stock prices.The Zacks rating relies solely on a company's changing earnings picture. It tracks EPS estimates for the current and following years from the sell-side analysts covering the stock through a consensus measure -- the Zacks Consensus Estimate.Since ...
Asbury Automotive (ABG) Upgraded to Buy: Here's What You Should Know
ZACKS· 2025-09-22 17:01
Core Viewpoint - Asbury Automotive Group (ABG) has received a Zacks Rank 2 (Buy) upgrade, indicating a positive trend in earnings estimates which is a significant factor influencing stock prices [1][4]. Earnings Estimates and Ratings - The Zacks rating system is primarily based on a company's changing earnings picture, tracking the Zacks Consensus Estimate for EPS from sell-side analysts [2]. - The Zacks rating upgrade for Asbury Automotive reflects an optimistic earnings outlook, likely leading to increased buying pressure and a rise in stock price [4][6]. Impact of Earnings Estimate Revisions - Changes in a company's future earnings potential, as shown by earnings estimate revisions, are strongly correlated with near-term stock price movements, particularly due to institutional investors' reliance on these estimates for fair value calculations [5]. - Rising earnings estimates and the subsequent rating upgrade for Asbury Automotive suggest an improvement in the company's underlying business, which should encourage investors to drive the stock price higher [6]. Zacks Rank System - The Zacks Rank stock-rating system categorizes stocks into five groups based on four earnings estimate-related factors, with a strong historical performance, particularly for Zacks Rank 1 stocks which have averaged a +25% annual return since 1988 [8]. - The upgrade of Asbury Automotive to a Zacks Rank 2 places it in the top 20% of Zacks-covered stocks, indicating a strong potential for market-beating returns in the near term [11]. Earnings Estimate Revisions for Asbury Automotive - For the fiscal year ending December 2025, Asbury Automotive is expected to earn $27.39 per share, unchanged from the previous year, but the Zacks Consensus Estimate has increased by 2.2% over the past three months [9].
Cidara Therapeutics (CDTX) Upgraded to Buy: Here's What You Should Know
ZACKS· 2025-09-22 17:01
Investors might want to bet on Cidara Therapeutics (CDTX) , as it has been recently upgraded to a Zacks Rank #2 (Buy). An upward trend in earnings estimates -- one of the most powerful forces impacting stock prices -- has triggered this rating change.A company's changing earnings picture is at the core of the Zacks rating. The system tracks the Zacks Consensus Estimate -- the consensus measure of EPS estimates from the sell-side analysts covering the stock -- for the current and following years.Since a chan ...